angiotensin-i and Blood-Loss--Surgical

angiotensin-i has been researched along with Blood-Loss--Surgical* in 1 studies

Trials

1 trial(s) available for angiotensin-i and Blood-Loss--Surgical

ArticleYear
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.
    Critical care (London, England), 2022, 07-28, Volume: 26, Issue:1

    Topics: Angiotensin I; Antifibrinolytic Agents; Blood Loss, Surgical; COVID-19; Double-Blind Method; Humans; Peptide Fragments; Pilot Projects; Tranexamic Acid; Treatment Outcome

2022